https://www.selleckchem.com/products/SRT1720.html
1; P .001), and high tumor grade (HR, 3.1; P .001) to be independent risk factors. For normal vs elevated CRP, KMA for RFS of stages 1-4 RCC revealed a 5-year RFS of 93% vs 88% (P=.001), 95% vs 83% (P=.163), 84% vs 62% (P=.001), and 58% vs 60% (P=.513), respectively. KMA MA KMA for OS of stages 1-4 RCC revealed a 5-year OS of 98% vs 81% (P=.001), 94% vs 80% (P=.103), 94% vs 65% (P=.001), and 99% vs 38% (P .001), respectively. Pretreatment CRP was an independent predictor of RFS and OS in an international multicenter cohor
Like
Comment
Share
